You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Autologous Hematopoietic Stem Cell Transplant

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Plasma Cell Myeloma, Secondary Amyloidosis Trial in Duarte, Nashville (procedure, biological, other, drug)

Recruiting
  • Plasma Cell Myeloma
  • Secondary Amyloidosis
  • Autologous Hematopoietic Stem Cell Transplantation
  • +3 more
  • Duarte, California
  • +1 more
Dec 27, 2021

Lymphoma Trial in Duarte (drug, other, procedure)

Active, not recruiting
  • Lymphoma
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Well-being of Caregivers (Caregiver Strain Index) Trial in Durham (home care)

Recruiting
  • Well-being of Caregivers (Caregiver Strain Index)
  • home care
  • Durham, North Carolina
    Duke University Medical Center
Jan 25, 2023

Hematopoietic Cell Transplantation Recipient, Plasma Cell Myeloma Trial in Houston (Ixazomib Citrate, Lenalidomide,

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • Plasma Cell Myeloma
  • Ixazomib Citrate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 8, 2022

HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,

Recruiting
  • HIV Infection
  • +10 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • La Jolla, California
  • +3 more
Dec 7, 2022

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Boston (biological, procedure, drug)

Terminated
Has Results
  • Myelodysplastic Syndrome
  • +2 more
  • GVAX
  • +6 more
  • Boston, Massachusetts
  • +3 more
Jun 30, 2022

Hematopoietic Cell Transplantation Recipient, Plasma Cell Myeloma Trial in Houston (biological, drug, other)

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • Plasma Cell Myeloma
  • Elotuzumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 2, 2022

Beta-Thalassemia Trial (CS-101 injection)

Not yet recruiting
  • Beta-Thalassemia
  • CS-101 injection
  • (no location specified)
Sep 27, 2023

Multiple Myeloma, Lymphoma Trial in Washington, Hackensack (Ipilimumab, Nivolumab)

Active, not recruiting
  • Multiple Myeloma
  • Lymphoma
  • Washington, District of Columbia
  • +1 more
Dec 2, 2021

Systemic Scleroderma Trial in Duarte (procedure, drug, radiation)

Recruiting
  • Systemic Scleroderma
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Mar 7, 2022

Blastic Plasmacytoid Dendritic Cell Tumor Trial in Houston (Tagraxofusp-erzs)

Active, not recruiting
  • Blastic Plasmacytoid Dendritic Cell Neoplasm
  • Tagraxofusp-erzs
  • Houston, Texas
    M D Anderson Cancer Center
Apr 8, 2022

Multiple Myeloma Trial in United States (procedure, drug, biological)

Completed
Has Results
  • Multiple Myeloma
  • Tumor Cell Collection
  • +6 more
  • San Francisco, California
  • +14 more
Jul 11, 2022

Multiple Myeloma Trial in Wuhan (Total Marrow irradiation,TMI, Autologous hematopoietic stem cell transplantation)

Recruiting
  • Multiple Myeloma
  • Total Marrow irradiation，TMI
  • Autologous hematopoietic stem cell transplantation
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jul 24, 2023

Hodgkin Disease, Hodgkin Lymphoma Trial run by the NCI (procedure, drug, radiation)

Terminated
Has Results
  • Hodgkin Disease
  • Hodgkin Lymphoma
  • Auto stem cell transplant
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 16, 2021

Recurrent Adult Hodgkin Lymphoma Trial in Duarte (biological, drug, other, procedure)

Active, not recruiting
  • Recurrent Adult Hodgkin Lymphoma
  • basiliximab
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in

Not yet recruiting
  • Systemic Sclerosis
  • SARS-CoV 2 Vaccination
    • (no location specified)
    Jul 24, 2023

    Myeloma, Lymphoma, Autologous Transplant Trial in Angers, Le Mans (Adapted Physical Activity)

    Recruiting
    • Myeloma
    • +2 more
    • Adapted Physical Activity
    • Angers, France
    • +1 more
    Oct 7, 2021

    Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)

    Recruiting
    • Plasma Cell Myeloma
    • Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 27, 2022

    Multiple Myeloma and Plasma Cell Tumor, Neurotoxicity Trial in Duarte (drug, genetic, other, procedure)

    Completed
    Has Results
    • Multiple Myeloma and Plasma Cell Neoplasm
    • Neurotoxicity
    • Duarte, California
      City of Hope Medical Center
    Aug 17, 2021

    (LTFU) of Patients Treated With Genome-edited Autologous

    Not yet recruiting
    • Sickle Cell Disease
    • OTQ923
    • (no location specified)
    Nov 24, 2023

    Hematologic Malignancy, Large B-cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Los Angeles (autologous hematopoietic stem

    Not yet recruiting
    • Hematologic Malignancy
    • +5 more
    • autologous hematopoietic stem cells added to planned CAR T
    • Los Angeles, California
      Cedars-Sinai Medical Center
    May 31, 2023

    Haploidentical Hematopoietic Stem Cell Transplantation Trial in Seoul (ATG-LDPTCy)

    Recruiting
    • Haploidentical Hematopoietic Stem Cell Transplantation
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Sep 11, 2023

    Multiple Sclerosis, Relapsing-Remitting Trial in La Jolla (Autologous hematopoietic stem cell transplantation,

    Recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • Autologous hematopoietic stem cell transplantation
    • +2 more
    • La Jolla, California
      Scripps Green Hospital
    Aug 16, 2022

    Lymphoma, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Non-Hodgkin Trial in United States (Autologous transplantation

    Completed
    Has Results
    • Lymphoma, B-Cell
    • +2 more
    • Autologous transplantation using rituxan/BEAM
    • Autologous transplantation using Bexxar/BEAM
    • New Haven, Connecticut
    • +35 more
    Oct 21, 2021

    COVID-19 Infection, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Seattle (Questionnaire Administration,

    Suspended
    • COVID-19 Infection
    • +2 more
    • Questionnaire Administration
    • Sotrovimab
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 24, 2023